Physician profile
Joshua Gilbert
NPI 1487015277
$2,279.53
in general payments reported to CMS, 2019-2025
14 companies · $374 in 2025
The $374 reported for 2025 was more than what 75% of Orthodontics and Dentofacial Orthopedics providers received nationally (typical 2025 total: $146).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $569 · 2020: $107 · 2021: $105 · 2022: $135 · 2023: $723 · 2024: $265 · 2025: $374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,215 · Gift: $147.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,215.43 |
| Gift | $147.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| American Orthodontics Corporation | $1,134.84 | 2019-2025 | Master Series, LP and Ifit Tubes, Empower-Metal |
| World Class Technology Corporation | $329.48 | 2019-2024 | Pitts21, Pitts21 Pro |
| Align Technology, INC. | $185.20 | 2020-2021 | |
| USA Angelalign Technology Corp | $170.94 | 2023-2025 | |
| Purelife, LLC | $130.00 | 2021-2025 | |
| Zimvie INC. | $66.39 | 2024 | |
| Forestadent USA, INC. | $54.58 | 2019 | |
| 3m Company | $47.89 | 2019-2020 | |
| Ormco Corporation | $39.34 | 2022-2023 | Miniendo II |
| Dentsply Sirona Orthodontics INC | $39.32 | 2019 | |
| Lightforce Orthodontics, INC. | $23.91 | 2023 | |
| Nobel Biocare USA | $22.91 | 2023 | Nobelactive |
| Envista Holdings Corporation | $19.03 | 2025 | Ortho Solo |
| Ultradent Products INC | $15.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joshua Gilbert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.